Current findings shed light on its pathogenesis and progression—and offer promising protocols to improve patients’ lives. As the initial impact of the COVID-19 pandemic subsides, health care practitioners are facing its weighty aftermath—long COVID, and its plethora of respiratory, neurologic, cardiovascular and other symptoms that can linger for weeks, monthsRead
Chemotherapy-induced peripheral neuropathy (CIPN) is a fairly common side effect of cancer treatment, affecting some 30-40 percent of patients. It occurs when the drugs used to treat cancer cause damage to nerves away from the brain and spinal cord, causing symptoms such as tingling, pain, burning, numbness, and loss ofRead
Providing patients with a curated selection of supplements can increase regimen compliance and introduce a new revenue stream to your practice. However, handling inventory is easily the most time-consuming, frustrating, and expensive aspect of providing this amenity. Here are a few best practices that can help you avoid common challengesRead
Use of certain cholesterol-lowering medication is increasing over time1 Nine out of 10 adults using a cholesterol-lowering medication take a statin1 Cholesterol-lowering statins can significantly lower the amount of CoQ10 (ubiquinone) in the blood3-6 Statins can lower the amount of CoQ10 in the body, even when a patient has taken a standard doseRead
Although both are forms of CoQ10, your body uses each nutrient differently to perform vital functions. Just as your car is powered by gas, your heart and other organs are powered by cellular energy. To create this energy, Ubiquinone, also known as the regular CoQ10, travels down a path inRead
Ubiquinol plays a supporting role in cellular energy production The mitochondria are responsible for producing 95% of the energy in the cells (aerobic metabolism), and Ubiquinol plays a critical role in the process, shuttling electrons4 CoQ10 is a member of the electron transport chain1 When CoQ10 receives electrons, the structureRead
In an 8-week, randomized, double-blind, placebo-controlled, single-center trial, with the primary outcome of change in flow-mediated dilation (FMD) in healthy patients with mild-to-moderate dyslipidemia, Ubiquinol significantly improved dyslipidemia-related endothelial dysfunction (P=0.001).
The role of Ubiquinol in restoring depleted levels of CoQ10 and improving ejection fraction1 In case reports of 29 cardiac patients, those patients who switched to Ubiquinol (average of 334 mg/day) from CoQ10 (average 384 mg/day) for 18 months experienced an increase in average serum CoQ10 level from 2.9 µg/mLRead
Acute myeloid leukemia (AML), the most common form of blood and bone marrow cancer among adults, is known for its rapid progression and resistance to treatment. “Treating acute myeloid leukemia is challenging because of these persistent, leukemia-initiating stem cells, which are typically not targeted by most existing therapies,” says SandeepRead
Because cardiomyopathy presenting as clinical heart failure is a condition typically involving multiple factors, there is no single clinical protocol that can be considered the optimal treatment plan.
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
